NCT06501131

Brief Summary

Previous studies have shown that the spectrum of light influences myopia. LED lights with a partially absent light spectrum increase the risk of myopia progression compared to LEDs with a full spectrum, potentially mediated by the excitability of the parasympathetic nervous system. This study intends to compare pupil size and area, as well as parameters regulated by the autonomic nervous system (such as skin bioelectrical activity and heart rate), between LEDs with a full visible spectrum and LEDs with a partially absent spectrum around 470nm and 730nm. We aim to elucidate the physiological mechanism underlying the effect of light spectrum on pupil changes and myopia.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2024

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 8, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 15, 2024

Completed
9 days until next milestone

Study Start

First participant enrolled

July 24, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2024

Completed
Last Updated

July 15, 2024

Status Verified

July 1, 2024

Enrollment Period

1 month

First QC Date

July 8, 2024

Last Update Submit

July 12, 2024

Conditions

Keywords

myopia,spectrum,vegetative nerve,pupil

Outcome Measures

Primary Outcomes (1)

  • pupil size

    The pupil diameter is measured in real-time using the Eyelink Portable Duo eye tracker.

    5 minutes

Secondary Outcomes (7)

  • Skin conductance response

    5 minutes

  • Respiratory movement

    5 minutes

  • Pulse pressure waveform

    5 minutes

  • Spherical equivalent refraction

    5 minutes

  • Uncorrected visual acuity

    5 minutes

  • +2 more secondary outcomes

Study Arms (2)

full spectrum light group

EXPERIMENTAL

Subjects were asked to stay in a resting state for 5 minutes in a dark room, then turn on the full-spectrum light and adapt to the light environment for 5 minutes, and then take measurements for 5 minutes. After wash-out in the dark room for 5 minutes, change the light to ordinary LED lamp and repeat the above test steps for measurement.

Other: full-spectrum light exposure

ordinary LED light group

EXPERIMENTAL

Subjects were asked to stay in a resting state for 5 minutes in a dark room, then turn on the ordinary LED lamp and adapt to the light environment for 5 minutes, and then take measurements for 5 minutes. After wash-out in the dark room for 5 minutes, change the light to full-spectrum light and repeat the above test steps for measurement.

Other: specific spectrum absence light exposure

Interventions

Subjects will stay in a room with full spectrum light for 5 minutes. After 5 minutes wash-out period, altenate to the other arm.

full spectrum light group

Subjects will stay in a room with ordinary LED light for 5 minutes. After 5 minutes wash-out period, altenate to the other arm.

ordinary LED light group

Eligibility Criteria

Age7 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • \. Age 7-45 years 2. Able to wear multi-channel physiological measurement devices and cooperate with experimental procedures.
  • \. Binocular? spherical power between -0.50 to -5.00 diopters, and cylinder power no more than -1.50 diopters.
  • \. Voluntarily participate in this study with informed consent form signed.

You may not qualify if:

  • \. History of diseases affecting autonomic nervous system function, such as depression and anxiety.
  • \. History of eye diseases such as strabismus, amblyopia, keratitis, and glaucoma, which are unsuitable for eye movement test.
  • \. History of major systemic diseases or surgeries such as cranial surgery, myocardial infarction, or stroke.
  • \. Systemic medication history that may affect autonomic nervous system function, including but not limited to antidepressants, antihistamines, anticholinergics, antipsychotics, and sedative-hypnotic drugs like diazepam or lorazepam.
  • \. Use of eyedrops such as mydriatics or miotics that will affect pupil size. 6. Having difficulty in understanding and cooperating with the trial, such as those with disabilities, communication barriers, or those unable to undertake examinations.
  • \. Other contradictions that the physician may consider inappropriate for enrolment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Myopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Central Study Contacts

Zeng Yangfa, Master's

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 8, 2024

First Posted

July 15, 2024

Study Start

July 24, 2024

Primary Completion

August 31, 2024

Study Completion

September 30, 2024

Last Updated

July 15, 2024

Record last verified: 2024-07